These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 3276494)

  • 41. [Amyloidosis in patients undergoing long-term hemodialysis: elucidation of etiological mechanism and therapeutic stratigy].
    Shimojyo F
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94 Suppl():56-60. PubMed ID: 15796057
    [No Abstract]   [Full Text] [Related]  

  • 42. Is beta 2-microglobulin a mediator of bone disease?
    Sprague SM; Popovtzer MM
    Kidney Int; 1995 Jan; 47(1):1-6. PubMed ID: 7731134
    [No Abstract]   [Full Text] [Related]  

  • 43. Beta 2-microglobulin-related amyloidosis in patients receiving chronic hemodialysis.
    Gejyo F; Homma N; Maruyama H; Arakawa M
    Contrib Nephrol; 1988; 68():263-9. PubMed ID: 3069321
    [No Abstract]   [Full Text] [Related]  

  • 44. Renal transplantation relieves the symptoms but does not reverse beta 2-microglobulin amyloidosis.
    Mourad G; Argilés A
    J Am Soc Nephrol; 1996 May; 7(5):798-804. PubMed ID: 8738817
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carpal tunnel syndrome caused by amyloid containing beta 2 microglobulin: a new amyloid and a complication of long term haemodialysis.
    McClure J; Bartley CJ; Ackrill P
    Ann Rheum Dis; 1986 Dec; 45(12):1007-11. PubMed ID: 3545104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beta 2-microglobulin amyloidosis in chronic renal failure.
    Zingraff JJ; Noel LH; Bardin T; Atienza C; Zins B; Drueke TB; Kuntz D
    N Engl J Med; 1990 Oct; 323(15):1070-1. PubMed ID: 2215569
    [No Abstract]   [Full Text] [Related]  

  • 47. Assessment of the stability of an immunoadsorbent for the extracorporeal removal of Beta-2-microglobulin from blood.
    Daniels CM; Woolverton EM; Sprague SM; Ameer GA
    Blood Purif; 2005; 23(4):287-97. PubMed ID: 15942167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beta2-microglobulin-induced cutaneous amyloidosis in a patient with long-term hemodialysis.
    Miyata T; Nakano T; Masuzawa M; Katsuoka K; Kamata K
    J Dermatol; 2005 May; 32(5):410-2. PubMed ID: 16043909
    [No Abstract]   [Full Text] [Related]  

  • 49. Osteoarticular disorders of renal origin: disease-related and iatrogenic.
    Kay J; Bardin T
    Baillieres Best Pract Res Clin Rheumatol; 2000 Jun; 14(2):285-305. PubMed ID: 10925746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathogenesis and management of dialysis-related amyloid bone disease.
    Nangaku M; Miyata T; Kurokawa K
    Am J Med Sci; 1999 Jun; 317(6):410-5. PubMed ID: 10372842
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathophysiology of advanced glycation end-products in renal failure.
    Miyata T; Iida Y; Horie K; Cai Z; Sugiyama S; Maeda K
    Nephrol Dial Transplant; 1996; 11 Suppl 5():27-30. PubMed ID: 9044303
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The gammagraphic diagnosis of dialysis-associated amyloidosis with beta 2-microglobulin-I-131. Preliminary results].
    Ponz E; Piera C; Campistol JM; Lomeña F; Pavía A; Herranz R; Muñoz Gómez J; Setoain J; Revert L
    Med Clin (Barc); 1990 Oct; 95(14):538-9. PubMed ID: 2084434
    [No Abstract]   [Full Text] [Related]  

  • 53. Beta-2-microglobulin: a possible new uremic toxin?
    Gejyo F; Brancaccio D
    Int J Artif Organs; 1988 Jan; 11(1):3-5. PubMed ID: 3283056
    [No Abstract]   [Full Text] [Related]  

  • 54. Hemodialysis-associated amyloidosis of bone of beta-2 microglobulin origin.
    Mikawa Y; Watanabe R; Yamano Y
    Arch Orthop Trauma Surg; 1990; 109(2):109-12. PubMed ID: 2180389
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systemic amyloidosis of beta 2-microglobulin type: a complication of long-term haemodialysis.
    Theaker JM; Raine AE; Rainey AJ; Heryet A; Clark A; Oliver DO
    J Clin Pathol; 1987 Oct; 40(10):1247-51. PubMed ID: 3119676
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin.
    Gejyo F; Yamada T; Odani S; Nakagawa Y; Arakawa M; Kunitomo T; Kataoka H; Suzuki M; Hirasawa Y; Shirahama T
    Biochem Biophys Res Commun; 1985 Jun; 129(3):701-6. PubMed ID: 3893430
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beta-2 microglobulin in ESRD: an in-depth review.
    Winchester JF; Salsberg JA; Levin NW
    Adv Ren Replace Ther; 2003 Oct; 10(4):279-309. PubMed ID: 14681859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beta-2-microglobulin-associated amyloidosis.
    Floege J; Ehlerding G
    Nephron; 1996; 72(1):9-26. PubMed ID: 8903856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A hip fracture in a dialysis patient with Aβ2M amyloidosis.
    Kazama JJ; Yamamoto S; Wakasugi M; Narita I
    Kidney Int; 2014 Jan; 85(1):214-5. PubMed ID: 24380913
    [No Abstract]   [Full Text] [Related]  

  • 60. Beta2-microglobulin and amyloidosis.
    Drüeke TB
    Nephrol Dial Transplant; 2000; 15 Suppl 1():17-24. PubMed ID: 10737162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.